ImmunoPrecise Antibodies Ltd

TQB

Company Profile

  • Business description

    ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.

  • Contact

    Industrious 823 Congress Avenue
    Suite 300
    AustinTX78701
    USA

    https://www.ipatherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 April 2026

    Employees

    101

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,688.0035.50-0.41%
CAC 407,537.5752.09-0.69%
DAX 4023,269.0181.54-0.35%
Dow JONES (US)42,455.29248.470.59%
FTSE 1008,758.0416.61-0.19%
HKSE23,689.13158.650.67%
NASDAQ19,606.13158.720.82%
Nikkei 22538,354.0949.14-0.13%
NZX 50 Index12,532.6536.40-0.29%
S&P 5006,008.0040.160.67%
S&P/ASX 2008,474.9030.60-0.36%
SSE Composite Index3,381.5821.690.65%

Market Movers